These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4346011)

  • 1. Passive protection of mice against intracerebral infections with Bordetella pertussis.
    Dolby JM
    J Hyg (Lond); 1972 Dec; 70(4):707-18. PubMed ID: 4346011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.
    Standfast AF; Dolby JM
    J Hyg (Lond); 1972 Sep; 70(3):487-501. PubMed ID: 4341998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.
    Dolby JM; Dolby DE; Bronne-Shanbury CJ
    J Hyg (Lond); 1975 Feb; 74(1):85-102. PubMed ID: 163275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse-protective properties of Bordetella pertussis serotypes in passive tests.
    Eldering G; Holwerda J; Baker J
    J Bacteriol; 1967 Jun; 93(6):1758-61. PubMed ID: 4290561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the antigen which elicits the bactericidal antibody and of the mouse-protective antigen on the growth of Bordetella pertussis in the mouse brain.
    Dolby JM; Ackers JP; Dolby DE
    J Hyg (Lond); 1975 Feb; 74(1):71-83. PubMed ID: 20475889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective antigens of Bordetella pertussis mouse-protection test against intracerebral and aerosol challenge of B. pertussis.
    Sato H; Sato Y
    Dev Biol Stand; 1985; 61():461-7. PubMed ID: 2872127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross protection studies on Bordetella bronchiseptica in mice using an intracerebral challenge model.
    Lendvai N; Magyar T; Semjén G
    Vet Microbiol; 1992 Jun; 31(2-3):191-6. PubMed ID: 1626369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor.
    Novotny P; Chubb AP; Cownley K; Montaraz JA; Beesley JE
    Dev Biol Stand; 1985; 61():27-41. PubMed ID: 2872113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanism of protection by live attenuated Bordetella pertussis BPZE1 against Bordetella bronchiseptica in mice.
    Kammoun H; Feunou PF; Foligne B; Debrie AS; Raze D; Mielcarek N; Locht C
    Vaccine; 2012 Aug; 30(40):5864-70. PubMed ID: 22814407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis in a murine model of respiratory infection.
    Watanabe M; Nagai M
    Infect Immun; 2001 Nov; 69(11):6981-6. PubMed ID: 11598073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against experimental Bordetella bronchiseptica infection in mice by active immunization with killed vaccine.
    Sekiya K; Kawahira M; Nakase Y
    Infect Immun; 1983 Aug; 41(2):598-603. PubMed ID: 6874070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-gamma-mediated protection against intracerebral challenge with Bordetella pertussis in mice.
    Sakurai S; Kamachi K; Konda T; Komuro K; Uchida T
    Jpn J Med Sci Biol; 1997 Feb; 50(1):35-43. PubMed ID: 9354968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of surface antigens in the protective potency of Bordetella pertussis suspensions as measured by the intracerebral challenge technique in mice.
    Holt LB; Spasojevíc V
    J Med Microbiol; 1968 Aug; 1(1):119-26. PubMed ID: 4318938
    [No Abstract]   [Full Text] [Related]  

  • 14. Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection.
    Bottero D; Gaillard ME; Errea A; Moreno G; Zurita E; Pianciola L; Rumbo M; Hozbor D
    Vaccine; 2013 Oct; 31(45):5262-8. PubMed ID: 24012570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of Bordetella pertussis preserved in liquid nitrogen as a challenge suspension in the Kendrick mouse protection test.
    Novotny P; Brookes JE
    J Biol Stand; 1975; 3(1):11-29. PubMed ID: 165201
    [No Abstract]   [Full Text] [Related]  

  • 16. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity.
    Wolfe DN; Goebel EM; Bjornstad ON; Restif O; Harvill ET
    Infect Immun; 2007 Oct; 75(10):4972-9. PubMed ID: 17698566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the immune response to pertussis vaccine during Plasmodium berghei yoelii infection in mice.
    Viens P; Tarzaali A; Quevillon M
    Am J Trop Med Hyg; 1974 Sep; 23(5):846-9. PubMed ID: 4375413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of the whole-cell pertussis vaccine produced in Poland against different Bordetella parapertussis isolates in the mouse intranasal challenge model.
    Zawadka M; Polak M; Rabczenko D; Mosiej E; Augustynowicz E; Lutyńska A
    Vaccine; 2011 Jul; 29(33):5488-94. PubMed ID: 21641954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of orally administered Bordetella pertussis vaccine in mice.
    Hof H; Finger H; Körner L; Milcke L
    Dev Biol Stand; 1976; 33():47-53. PubMed ID: 182602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the immunizing capacity of orally administered particulate antigens. I. The efficiency of killed Bordetella pertussis cells.
    Hof H; Finger H; Körner L; Milcke L
    Zentralbl Bakteriol Orig A; 1975; 230(2):210-22. PubMed ID: 167535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.